Bortezomib (Page 8 of 8)

Principal Display Panel

​NDC 72266-243-01

BORTEZOMIB (bortezomib) INJECTION

3.5 mg per 3.5 mL

(1 mg per mL)

FOR INTRAVENOUS USE ONLY

READY-to-use Vial

​SINGLE DOSE VIAL

DISCARD UNUSED PORTION

CAUTION: Hazardous Agent

Vial Label 3.5 mg/ 3.5 mL

Bortezomib Injection 3.5 mg per 3.5 mL
(click image for full-size original)

Carton Label 3.5 mg/ 3.5 mL

Carton Label 1 mg
(click image for full-size original)

​NDC 72266-244-01

BORTEZOMIB​(bortezomib) INJECTION

3.5 mg per 1.4 mL

(2.5 mg per mL)

FOR INTRAVENOUS USE ONLY

​Ready-to-use Vial

CAUTION: Hazardous Agent

Vial Label 3.5 mg/ 1.4 mL

Bortezomib Injection 3.5 mg per 1.4 mL
(click image for full-size original)

Carton Label 3.5 mg/ 1.4 mL

Carton Label 2.5 mg
(click image for full-size original)
BORTEZOMIB
bortezomib injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72266-243
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BORTEZOMIB (BORTEZOMIB) BORTEZOMIB 1 mg
Inactive Ingredients
Ingredient Name Strength
MANNITOL 10 mg
SODIUM ACETATE 0.82 mg
DIMETHYL SULFOXIDE 20 mg
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72266-243-01 1 INJECTION in 1 VIAL, SINGLE-DOSE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA215331 08/23/2022
BORTEZOMIB
bortezomib injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72266-244
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BORTEZOMIB (BORTEZOMIB) BORTEZOMIB 2.5 mg
Inactive Ingredients
Ingredient Name Strength
MANNITOL 25 mg
SODIUM ACETATE 0.82 mg
DIMETHYL SULFOXIDE 22 mg
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72266-244-01 1 INJECTION in 1 VIAL, SINGLE-DOSE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA215331 08/23/2022
Labeler — FOSUN PHARMA USA INC (080920998)
Establishment
Name Address ID/FEI Operations
Gland Pharma Limited 918601238 manufacture (72266-243), manufacture (72266-244)

Revised: 08/2022 FOSUN PHARMA USA INC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.